Cigna Hits the Brakes on Their New Modifier 25 Policy

Date: May 24, 2023

Following fierce opposition from the physician community, the insurer Cigna announced today a delay in implementing a policy (PDF) that would have required submitting medical records to support the use of modifier -25 on evaluation and management (E/M) services when billed with a minor procedure. The delay applies to all states.

Physicians in most states would have had to comply with the policy beginning Thursday, May 25, but Cigna said it would pause implementation and continue to review it. The payer had previously delayed implementation in only a handful of states (California, Colorado, Kentucky, Ohio, and Texas). Cigna has now delayed the policy until an unspecified date for all states.

Modifier -25 signifies that on the day a procedure was performed, the patient’s condition required a significant, separately identifiable E/M service (CPT codes 99212-99215).

Under Cigna’s policy, providers would have had to schedule separate evaluation and management visits to avoid the added paperwork and risk of denials. Additional visits would have threatened patients’ adherence to treatment plans and increased their co-payments.

“We are evaluating feedback from our provider partners about this update, and we expect to implement this policy update at a future time. Providers will be notified in advance of the new implementation date after we complete our evaluation,” Cigna Medical Director Ari Gutman, MD, MBA, FAAD, said.

We are happy to assist you with claims issues and other topics related to eye care.  Check back often for updated News Items related to billing, documentation, and operations related to your practices.  Stay safe.

Recent News

Code Implementation Dates

Last week the AMA published information about several important coding and billing updates that will affect claims submission, and compliance in your practice and ASC. ...

Properly Billing for Intravitreal Injections with E/M Code 99211-99215 and Modifier 25

CMS TPE audits of intravitreal injections and the accompanying office visit continue. Practices involved in these reviews often question what auditors are looking for. These reviews ...

Medicare Contractor WPS Incorporates ASCRS/AAO Recommendations on Proposed Local Coverage Determination for Cataract Surgery

Medicare Administrative Contractor (MAC) Wisconsin Physicians Service Insurance Corporation (WPS) released its final version of the LCD. In this edition, WPS brings the proposed LCD ...

iDose New Permanent J code

In December 2023, the US Food and Drug Administration approved iDose TR for a single administration per eye intracameral implant that continuously releases travoprost, indicated for ...

Federal Trade Commission Eyeglass Rule

Concluding a comprehensive multi-year review, the Federal Trade Commission (FTC) has announced final updates to its Ophthalmic Practice Rules, known as the Eyeglass Rule, aimed at ...

CMS Extends Deadline for MIPS 2023 Data Submission

CMS has extended the data submission period for the Merit-based Incentive Payment System (MIPS) eligible clinicians who participated in the 2023 performance year of the ...

Congress Passed bill for MPFS

The recent passing of a partial government funding bill by Congress on March 8 is important to Medicare beneficiaries. This bill includes policies aimed at addressing ...

Change to Processing for Telehealth Services Billed with POS 10

In calendar year (CY) 2024, the Centers for Medicare & Medicaid Services (CMS) issued a change to processing for telehealth services billed with POS 10. ...

Diabetes Cost Measure Misattributed to Ophthalmologists

The American Society of Cataract and Refractive Surgery (ASCRS), the American Society of Retina Specialists (ASRS) and the American Academy of Ophthalmology (AAO), met recently ...

Review Your 2022 MIPS Performance Feedback and Final Scores

The Centers for Medicare & Medicaid Services (CMS) has released the Merit-Based Incentive Payment System (MIPS) performance feedback and final scores for the 2022 performance ...

JZ Modifier Required July 1, 2023

The much-anticipated mandatory reporting of the JZ modifier for Part B Medicare begins July 1, 2023.  The new Medicare policy can be found here.  The ...

Medical Consulting Group and Corcoran Consulting Group Announce Merger

Springfield, MO, April 27th, 2023. Medical Consulting Group (MCG), a provider of consulting services to ophthalmic practices and companies, and Corcoran Consulting Group (CCG), a ...

IHEEZO Gel gains Medicare Pass-Through

On March 13, 2023, Harrow® announced that the Centers for Medicare & Medicaid Services (CMS) has approved transitional pass-through reimbursement status for chloroprocaine hydrochloride ophthalmic ...

Cigna Change Modifier 25 Policy

As a result of a recent review, Cigna has announced it will require the submission of office notes with claims submitted for evaluation and management ...

Congress makes positive adjustments that affect ophthalmologists

In this Healio Video Perspective from Hawaiian Eye 2023, Kevin J. Corcoran, COE, CPC, CPMA, FNAO, discusses ophthalmic economic and regulatory updates for the year. ...